StockMarketWire.com - Graphene nanoplatelets products maker Directa Plus said new business wins had boosted sales from the start of the year to 1 October.

Sales for the period 1 January 2020 to 1 October 2020 increased to €3.0m from €2.6m seen in equivalent previous period.

The company said 132 new contracts had been signed since 1 January 2020.

Contracted order book was expected to generate revenue of €4.0m during 2021 and €3.0m during 2022, it added.

'Post-acquisition integration continues to progress well and the company continues to invest to reshape the Setcar business to ensure better growth opportunities.'




At 9:44am: [LON:DCTA] Directa Plus Plc share price was +1.5p at 70.5p



Story provided by StockMarketWire.com